Synapse - Hematologic Malignancies, Division of

Results (13379)

A randomized placebo controlled study of a plant-based dietary versus supplement versus placebo intervention in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) study

Meeting Abstract

Shah, U. A.; Castro, F.; Anuraj, A.; Schach, E.; Derkach, A.; Joseph, N. S.; Adintori, P. A.; Guttentag, L.; Blaslov, J.; Cross, J. R.; more...
Blood (2022)

Fulltext@MSK | Save

A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression

Meeting Abstract

Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
Blood (2022)

Fulltext@MSK | Save

Multivariable analyses of prognostic factors for progression-free survival (PFS) and complete response (CR) with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus RVd plus autologous stem cell transplantation (ASCT) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) in the DETERMINATION phase 3 trial

Meeting Abstract

Hassoun, H.; Jacobus, S. J.; Richardson, P. G.; Zonder, J. A.; Voorhees, P. M.; Kaufman, J. L.; Yee, A. J.; Scott, E. C.; Torka, P.; Libby, E.; more...
Blood (2022)

Fulltext@MSK | Save

Gut microbiome composition is associated with engraftment syndrome in multiple myeloma patients undergoing autologous stem cell transplantation

Meeting Abstract

Feinman, R.; Aptekmann, A. A.; Colorado, I.; Roy, S.; Zenreich, J.; Dar, S. H.; Aleman, A.; Unawane, R.; Zhuang, M.; Korkoleo, M.; more...
Blood (2022)

Fulltext@MSK | Save

A 3-year follow-up comparison of clinical outcomes from Zuma-5 (axicabtagene ciloleucel) and the international scholar-5 external control cohort in relapsed/refractory follicular lymphoma (R/R FL)

Meeting Abstract

Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Owen, J.; Kanters, S.; Bobillo, S.; Ribeiro, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
Blood (2022)

Fulltext@MSK | Save

Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations

Meeting Abstract

DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
Blood (2022)

Fulltext@MSK | Save

Outcomes and management of SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation (HCT) and CAR-T therapy

Meeting Abstract

Infante, M. S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Politikos, I.; Barker, J. N.; Babady, N. E.; Ramanathan, L.; Seo, S.; more...
Blood (2022)

Fulltext@MSK | Save

Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy

Meeting Abstract

Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
Blood (2022)

Fulltext@MSK | Save

Interim phase I clinical data of FT819-101, a study of the first-ever, off-the-shelf, iPSC-derived TCR-less CD19 CAR T-cell therapy for patients with relapsed/refractory B-cell malignancies

Meeting Abstract

Mehta, A.; Farooq, U.; Chen, A.; McGuirk, J. P.; Ly, T.; Wong, L.; Cooley, S.; Valamehr, B.; Elstrom, R.; Chu, Y. W.; more...
Blood (2022)

Fulltext@MSK | Save

Universal updated phase 1 data highlights role of allogeneic anti-BCMA ALLO-715 therapy for relapsed/refractory multiple myeloma

Meeting Abstract

Mailankody, S.; Matous, J. V.; Liedtke, M.; Sidana, S.; Oluwole, O. O.; Mohan, M.; Cruz, J. C.; Nath, R.; Anwer, F.; Rossi, A.; more...
Blood (2022)

Fulltext@MSK | Save